Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely ...

We recently published a list of Jim Cramer Recently Discussed These 15 Stocks. In this article, we are going to take a look ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Pfizer ...

High-yielding dividend stocks may not be the ticket to superior returns, but they can rank pretty high on the list of nice-to ...

Pfizer halted its oral obesity drug, danuglipron, in April 2025 due to liver injury concerns, a major pipeline setback. Find ...

Although Pfizer has made some efforts to turn things around, they have been insufficient. Pfizer's poor performance since ...

SSGJ-707 has shown initial effic NEW YORK, April 29, 2025--Pfizer Inc. (NYSE: PFE) reported financial results for the first quarter of 2025 and reaffirmed its 2025 financial guidance(1).

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Investors in Pfizer Inc (Symbol: PFE) saw new options begin trading today, for the September 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.